天美传媒

Endometriosis; Pregnancy; Adverse pregnancy outcomes; Fertility; Miscarriage; Preterm birth; Placenta previa; Ectopic pregnancy; Gestational hypertension; Assisted Reproductive Technologies (ART); Deep Infiltrating Endometriosis (DIE); Maternal-fetal outcomes

Introduction

This review explores the complex interplay between endometriosis and pregnancy, highlighting its potential impact on fertility and various obstetric complications. It details how pregnancy can alter endometriosis symptoms and progression, alongside discussing the risks of spontaneous abortion, preterm birth, and placenta previa in affected individuals. The article emphasizes the need for tailored management strategies to optimize maternal and fetal outcomes [1].

This systematic review and meta-analysis rigorously assesses the association between endometriosis and adverse pregnancy outcomes. Findings suggest a significantly increased risk of preterm birth, miscarriage, placenta previa, and ectopic pregnancy in women with endometriosis, underscoring the condition's profound impact on reproductive health. It advocates for increased monitoring and specialized care for pregnant women diagnosed with endometriosis [2].

This prospective study investigates perinatal outcomes in pregnancies from women with and without endometriosis, differentiating between spontaneous conception and Assisted Reproductive Technologies (ART). It indicates that endometriosis itself, rather than the mode of conception, is a significant risk factor for adverse perinatal events, including preterm birth and lower birth weight, highlighting the intrinsic risks associated with the condition during pregnancy [3].

This meta-analysis synthesized evidence on adverse pregnancy outcomes in women with endometriosis, reinforcing previous findings. It identifies a heightened risk for gestational hypertension, preterm birth, miscarriage, and placental complications. The study underscores the need for vigilant prenatal care for this patient population to mitigate potential risks and improve maternal-fetal well-being [4].

This study specifically investigates the impact of endometriosis on pregnancy outcomes in women who conceived via In Vitro Fertilization/IntraCytoplasmic Sperm Injection (IVF/ICSI). It reveals that even after successful ART, endometriosis can still lead to increased risks of adverse obstetric complications, including miscarriage and ectopic pregnancy, suggesting that the underlying disease pathology continues to influence pregnancy outcomes. The findings highlight the importance of thorough counseling for these patients [5].

This review focuses on the specific challenges of Deep Infiltrating Endometriosis (DIE) during pregnancy. It discusses how DIE, a severe form of the disease, is associated with a higher incidence of surgical interventions during pregnancy, premature rupture of membranes, and preterm birth. The article emphasizes the need for specialized multidisciplinary care for pregnant women with DIE to manage potential complications effectively [6].

This updated systematic review and meta-analysis consolidates the latest evidence on endometriosis and adverse pregnancy outcomes. It confirms elevated risks for miscarriage, preterm birth, placenta previa, and gestational hypertension. The study's comprehensive analysis provides robust data supporting the need for clinicians to recognize endometriosis as a significant risk factor during pregnancy and to implement appropriate monitoring and intervention strategies [7].

This large prospective cohort study examines maternal and neonatal outcomes in women with endometriosis, providing real-world data on the pregnancy risks. It found an increased incidence of preterm birth, gestational diabetes, and postpartum hemorrhage in affected women. The study emphasizes the long-term implications of endometriosis, extending beyond conception to impact the entire pregnancy and postpartum period [8].

This review provides a comprehensive overview of endometriosis in the context of pregnancy, covering its pathophysiology, implications for fertility, and various pregnancy complications. It details how the hormonal milieu of pregnancy can influence endometriosis lesions and discusses the elevated risks of miscarriage, ectopic pregnancy, and preterm labor. The article highlights the complex management decisions involved in caring for these patients [9].

This systematic review and meta-analysis specifically of cohort studies investigates the link between endometriosis and adverse pregnancy outcomes. It confirms that women with endometriosis face a significantly increased risk of various complications, including spontaneous abortion, preterm birth, and placenta previa. The study's focus on cohort designs lends strong evidence to the causality between endometriosis and these adverse outcomes, emphasizing the need for proactive risk management [10].

Description

Endometriosis significantly complicates pregnancy, impacting both fertility and subsequent obstetric outcomes. Several narrative reviews delve into this complex interplay, detailing how pregnancy might alter endometriosis symptoms and progression, while consistently noting elevated risks for spontaneous abortion, preterm birth, and placenta previa. These comprehensive works stress the necessity for tailored management to optimize maternal and fetal well-being throughout gestation [1, 9]. The hormonal environment characteristic of pregnancy can indeed influence the activity and presentation of endometriosis lesions, yet it is evident that the underlying disease pathology itself continues to exert a profound influence, consistently contributing to a range of adverse events. This necessitates a proactive and informed approach to care for these patients.

Robust systematic reviews and meta-analyses provide compelling evidence, solidifying the associations between endometriosis and unfavorable pregnancy outcomes. For instance, collective findings from a systematic review and meta-analysis indicate a significantly increased risk of preterm birth, miscarriage, placenta previa, and ectopic pregnancy in women with endometriosis, thereby underscoring the condition's profound effect on overall reproductive health [2]. Other meta-analyses further reinforce these critical observations, consistently identifying heightened risks for gestational hypertension, preterm birth, miscarriage, and various placental complications, adding to the growing body of evidence [4, 7]. A systematic review and meta-analysis specifically focusing on cohort studies adds significant weight, lending strong evidence to the causality between endometriosis and complications such as spontaneous abortion, preterm birth, and placenta previa. This type of evidence strongly emphasizes the critical need for proactive risk management strategies tailored for this population [10]. Collectively, this extensive and comprehensive body of evidence firmly supports the imperative for clinicians to recognize endometriosis as a substantial risk factor during pregnancy and to promptly implement appropriate monitoring and intervention strategies to safeguard both mother and child.

Beyond the aggregated data from reviews, individual prospective studies offer invaluable, real-world insights into perinatal and maternal-neonatal outcomes. One large prospective study meticulously investigated perinatal outcomes in pregnancies from women with and without endometriosis, thoughtfully differentiating between spontaneous conception and Assisted Reproductive Technologies (ART). The study convincingly concluded that endometriosis itself, rather than the specific mode of conception, serves as a significant and intrinsic risk factor for adverse perinatal events, prominently including preterm birth and lower birth weight [3]. Another substantial prospective cohort study further illuminated a broader spectrum of maternal and neonatal outcomes, identifying an increased incidence of preterm birth, gestational diabetes, and postpartum hemorrhage in affected women. This vital research emphasizes that the long-term implications of endometriosis extend significantly beyond the initial act of conception, impacting the entire pregnancy trajectory and even reaching into the postpartum period [8]. These findings collectively underscore the chronic and pervasive nature of endometriosis's influence on reproductive health.

The challenges posed by endometriosis persist even when medical assistance is sought for conception. Critically, even after successful In Vitro Fertilization (IVF) or IntraCytoplasmic Sperm Injection (ICSI), endometriosis can still lead to increased risks of adverse obstetric complications, specifically including miscarriage and ectopic pregnancy. This observation strongly suggests that the inherent underlying disease pathology continues to influence pregnancy outcomes irrespective of conception method, highlighting the paramount importance of thorough counseling for these patients regarding potential ongoing risks [5]. Furthermore, particularly severe manifestations of the disease, such as Deep Infiltrating Endometriosis (DIE), introduce an additional layer of complexity and specific challenges during pregnancy. DIE is distinctly associated with a higher incidence of surgical interventions during pregnancy, along with increased risks of premature rupture of membranes and preterm birth. Effectively managing these intricate cases undeniably calls for specialized, multidisciplinary care involving a team of experts to navigate the potential complications [6]. Overall, a consistent theme emerges across all research: increased monitoring and specialized, personalized care are universally advocated for pregnant women diagnosed with endometriosis. This tailored approach is essential to mitigate potential risks, improve maternal-fetal well-being, and ultimately optimize outcomes across all multifaceted aspects of the condition [2, 4, 7].

Conclusion

Endometriosis significantly impacts reproductive health, presenting complex challenges during pregnancy. Research consistently shows an increased risk of adverse pregnancy outcomes in women with endometriosis. These complications include spontaneous abortion, preterm birth, placenta previa, and ectopic pregnancy. Studies employing systematic reviews and meta-analyses robustly confirm these elevated risks, often also identifying gestational hypertension and placental complications as concerns. Beyond these, prospective studies reveal higher incidences of lower birth weight and, in some cases, gestational diabetes and postpartum hemorrhage. Even for pregnancies achieved through Assisted Reproductive Technologies (ART), endometriosis pathology continues to influence outcomes, necessitating thorough counseling. Specific severe forms, like Deep Infiltrating Endometriosis (DIE), introduce additional challenges such as increased need for surgical interventions during pregnancy and premature rupture of membranes. The condition's long-term implications extend across the entire pregnancy and postpartum period. Consequently, experts emphasize the critical need for increased monitoring, specialized multidisciplinary care, and tailored management strategies for pregnant individuals diagnosed with endometriosis to optimize both maternal and fetal well-being, mitigate potential risks, and improve overall outcomes. Recognizing endometriosis as a significant risk factor is paramount for clinicians.

References

• Stefano C, Maria PR, Federica R (2024 Mar 22) .Diagnostics (Basel) 14:588.

, ,

• Zaid A, Ahmed A, Manal A (2023 Jul 8) .Sci Rep 13:11059.

, ,

• Valentina P, Federica P, Paola S (2023 Dec) .J Matern Fetal Neonatal Med 36:2216893.

, ,

• Guanting L, Hongli Z, Xianghua Z (2022 Mar) .J Obstet Gynaecol Res 48:588-601.

, ,

• Zhaowei L, Jingyi T, Yueping J (2022 Oct 28) .Front Endocrinol (Lausanne) 13:994248.

, ,

• Eleonora C, Simone F, Federica C (2022 Dec) .Minerva Obstet Gynecol 74:569-586.

, ,

• Lingxuan Q, Jiafeng H, Yan Z (2021) .Gynecol Obstet Invest 86:111-125.

, ,

• Giulia B, Carlo A, Sara M (2021 May) .J Matern Fetal Neonatal Med 34:1679-1685.

, ,

• Zakiya HM, Peter PKL, Cindy YHL (2020 Aug) .Reprod Sci 27:1475-1485.

, ,

• Ruoyan H, Yunyan L, Lu L (2020 Sep-Oct) .J Minim Invasive Gynecol 27:1259-1271.

, ,